Skip to main content

Table 1 Patients’ demographic, clinical and lifestyle characteristics collected at T0 assessment: the whole cohort and those who completed follow-up at T3

From: Weight and waist-to-hip ratio change pattern during the first five years of survival: data from a longitudinal observational Chinese breast cancer cohort

Characteristics

The whole cohort(n = 1462), n (%)

who completed follow-up at T3, (n = 1117), n (%)

Time from diagnosis to T0 assessment, median (range), months

3.2 (0.1–11.9)

3.2 (0.1–11.9)

Age at diagnosis, mean (SD), years

51.9 (9.1)

51.9 (8.8)

Age group at diagnosis, years

 < 40

150 (10.3)

111 (9.5)

 40–49

468 (32.0)

383 (32.7)

 50–59

552 (37.7)

444 (37.9)

 ≥60

292 (20.0)

233 (19.9)

Education level

 High school or below

1230 (84.1)

987 (84.3)

 College or above

232 (15.9)

184 (15.7)

Marital status

 Married or cohabitation

1039 (71.1)

840 (71.7)

 Unmarried or divorced or widowed

423 (28.9)

331 (28.3)

Family income, HKD/month

 < 15,000

683 (46.7)

530 (45.3)

 15,000-30,000

452 (30.9)

375 (32.0)

 30,000-50,000

204 (14.0)

174 (14.9)

 ≥50,000

123 (8.4)

92 (7.9)

Employment status

 Full time

545 (37.3)

433 (37.0)

 Part time

195 (13.3)

146 (12.5)

 Not working

722 (49.4)

592 (50.6)

Number of comorbidities

 0

901 (61.6)

726 (62.0)

 1

371 (25.4)

296 (25.3)

 ≥2

190 (13.0)

149 (12.7)

Menopausal status at T0 assessment

 Pre-menopausal

782 (53.5)

627 (53.5)

 Post-menopausal

680 (46.5)

544 (46.5)

Parity

 0

339 (23.2)

281 (24.0)

 1

340 (23.3)

260 (22.2)

 2

531 (36.3)

429 (36.6)

 ≥3

252 (17.2)

201 (17.2)

AJCC stage

 0-I

523 (35.8)

438 (37.4)

 II

652 (44.6)

529 (45.2)

 III

276 (18.9)

197 (16.8)

 Missing

11 (0.8)

7 (0.6)

Histology

 IDC

1225 (83.8)

982 (83.8)

 ILC

42 (2.9)

35 (3.0)

 DCIS

94 (6.3)

70 (6.0)

 Others

101 (6.9)

84 (7.2)

ER status, %

 Positive

1057 (72.3)

870 (74.3)

 Negative

363 (24.8)

272 (23.2)

 Missing

42 (2.9)

29 (2.5)

PR status, %

 Positive

810 (55.4)

675 (57.6)

 Negative

605 (41.4)

463 (39.5)

 Missing

47 (3.2)

33 (2.8)

HER 2 status, %

 Positive

381 (26.1)

305 (26.0)

 Negative

966 (66.1)

786 (67.1)

 Missing

115 (7.9)

80 (6.8)

Type of surgery

 Mastectomy

917 (62.7)

714 (61.0)

Conservation

545 (37.3)

457 (39.0)

 Chemotherapy, %

 Yes

1100 (75.2)

875 (74.7)

 No

362 (24.8)

296 (25.3)

Radiotherapy, %

 Yes

1032 (70.6)

825 (70.5)

 No

430 (29.4)

346 (29.5)

Endocrine therapy, %

 Yes

1054 (72.1)

875 (74.7)

 No

408 (27.9)

296 (25.2)

Height, median (range), cm

156 (137–177)

156 (137–177)

Weight, median (range), kg

56.0 (33.4–111.0)

55.4 (34.3–110.0)

BMI at diagnosis, kg/m2

 Underweight (< 18.5)

53 (3.6)

51 (4.4)

 Normal (18.5–22.9)

713 (48.8)

540 (46.1)

 Overweight (23–24.9)

297 (20.3)

251 (21.4)

 Obese (≥25)

399 (27.3)

329 (28.1)

 Waist circumference, median (range), cm

80.3 (58.5–126.5)

80.2 (58.5–126.5)

 Hip circumference, median (range), cm

95.0 (78.0–136.5)

95.0 (78.0–135.0)

WHR at T0 assessment

 < 0.85

762 (52.1)

607 (51.8)

 ≥0.85

701 (47.9)

564 (48.2)

Sports participation 1-year before diagnosis

 Never

666 (45.6)

530 (45.3)

 Rarely/occasionally

487 (33.1)

399 (34.1)

 Frequently

309 (21.1)

242 (20.7)

Dietary energy intake 1-year before diagnosis, median (range), kcal/day

1620.3 (551.1–5787.3)

1616.6 (551.1–5787.3)

Dietary carbohydrate intake1-year before diagnosis, median (range), kcal/day

121.2 (56.9–191.2)

121.3 (56.9–191.2)

Dietary fat intake 1-year before diagnosis, median (range), g/1000 kcal/day

39.1 (14.2–62.7)

39.0 (14.2–62.7)

Coffee intake 1-year before diagnosis, ml/week

 < 200

991 (67.8)

785 (67.0)

 ≥200

471 (32.2)

386 (33.0)

Sugar-sweetened beverage intake1-year before diagnosis, ml/week

 < 200

1178 (80.6)

952 (81.3)

 ≥200

284 (19.4)

219 (18.7)

Vegetables and fruits intake 1-year before diagnosis, g/day

 < 400

496 (33.9)

399 (34.1)

 ≥400

966 (66.1)

772 (65.9)

Ever smoking before diagnosis

 Yes

22 (1.5)

21 (1.8)

 No

1440 (98.5)

1150 (98.2)

Ever frequent alcohol intake before diagnosis (>  4 times/week)

 Yes

28 (1.9)

16 (1.4)

 No

1434 (98.1)

1155 (98.6)

  1. Abbreviations: SD standard deviation; HKD Hong Kong dollars; BMI body mass index; AJCC American joint Committee on cancer; IDC invasive ductal carcinoma; ILC invasive lobular carcinoma; DCIS ductal carcinoma in situ; ER estrogen receptor; PR progesterone receptor; HER 2 human epidermal-growth-factor receptor 2; MET metabolic equivalent of task; g gram